183 related articles for article (PubMed ID: 22932889)
21. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
22. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation.
Yenamandra SP; Klein G; Kashuba E
Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394
[TBL] [Abstract][Full Text] [Related]
23. The association of Epstein-Barr virus infection with multiple myeloma.
Sadeghian MH; Ayatollahi H; Keramati MR; Memar B; Jamedar SA; Avval MM; Sheikhi M; Shaghayegh G
Indian J Pathol Microbiol; 2011; 54(4):720-4. PubMed ID: 22234097
[TBL] [Abstract][Full Text] [Related]
24. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
Yamashita Y; Tsurumi T; Mori N; Kiyono T
Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
[TBL] [Abstract][Full Text] [Related]
25. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
26. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
Exp Cell Res; 2005 Feb; 303(1):47-55. PubMed ID: 15572026
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.
Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F
J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037
[TBL] [Abstract][Full Text] [Related]
29. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
Imadome K; Shirakata M; Shimizu N; Nonoyama S; Yamanashi Y
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7836-40. PubMed ID: 12805559
[TBL] [Abstract][Full Text] [Related]
30. Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients.
Jing F; Wei D; Wang D; Li N; Cui F; Yang F; Chen Z; Huang X
Acta Neurol Scand; 2013 Nov; 128(5):345-50. PubMed ID: 23668247
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.
Anastasiadou E; Garg N; Bigi R; Yadav S; Campese AF; Lapenta C; Spada M; Cuomo L; Botta A; Belardelli F; Frati L; Ferretti E; Faggioni A; Trivedi P
Int J Cancer; 2015 Sep; 137(6):1491-7. PubMed ID: 25704079
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr-virus-induced interstitial lung disease.
Marzouk K; Corate L; Saleh S; Sharma OP
Curr Opin Pulm Med; 2005 Sep; 11(5):456-60. PubMed ID: 16093822
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of Epstein-Barr virus-encoded RNA1 and viral latent membrane protein 1 in osteosarcoma: A novel insight of predictive markers.
Mardanpour K; Rahbar M; Mardanpour S; Khazaei S; Rezaei M
Tumour Biol; 2020 Nov; 42(11):1010428320974247. PubMed ID: 33234011
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-driven bone marrow aplasia and plasmacytosis mimicking a plasma cell neoplasm.
Desborough MJ; Grech H
Br J Haematol; 2014 May; 165(3):272. PubMed ID: 24405048
[No Abstract] [Full Text] [Related]
35. [Long-term culture of plasma cells from patients with myeloma and establishment of a permanent cell line].
Stöckbauer P; Spicka I; Otevrelová P; Straub J; Hradcová M; Klener P
Sb Lek; 2002; 103(3):371-7. PubMed ID: 12688181
[TBL] [Abstract][Full Text] [Related]
36. CD40 signaling activated by Epstein-Barr virus promotes cell survival and proliferation in gastric carcinoma-derived human epithelial cells.
Imadome K; Shimizu N; Yajima M; Watanabe K; Nakamura H; Takeuchi H; Fujiwara S
Microbes Infect; 2009 Mar; 11(3):429-33. PubMed ID: 19397878
[TBL] [Abstract][Full Text] [Related]
37. Plasmablastic extramedullary plasmacytoma associated with Epstein-Barr virus arising in an immunocompetent patient with multiple myeloma.
Sasaki S; Hashimoto K; Nakatsuka S; Hasegawa M; Nakano T; Nagata S; Kanakura Y; Hayashi N
Intern Med; 2011; 50(21):2615-20. PubMed ID: 22041368
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus associated smooth muscle tumors in post transplant pediatric patients two cases of rare locations, and review of the literature.
Elawabdeh N; Cone BM; Abramowsky CR; Wrubel DM; Grossniklaus H; Walrath J; Bashir MZ; Shehata BM
Fetal Pediatr Pathol; 2013 Jun; 32(3):184-91. PubMed ID: 23445451
[TBL] [Abstract][Full Text] [Related]
39. The association of Epstein-Barr virus infection with multiple myeloma.
Khan G
Indian J Pathol Microbiol; 2012; 55(2):266-7. PubMed ID: 22771668
[No Abstract] [Full Text] [Related]
40. Epstein-Barr virus infection is associated to patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Mameli G; Fozza C; Niegowska M; Corda G; Ruda MF; Barraqueddu F; Dessì L; Podda L; Dore F; Sechi LA
Leuk Lymphoma; 2017 Feb; 58(2):466-469. PubMed ID: 27268403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
